| Therapeutic host-directed strategies to improve outcome in tuberculosis C Young, G Walzl, N Du Plessis Mucosal immunology 13 (2), 190-204, 2020 | 188 | 2020 |
| Potential therapeutic benefits of green and fermented Rooibos (Aspalathus linearis) in dermal wound healing NA Pringle, TC Koekemoer, A Holzer, C Young, L Venables, ... Planta medica 84 (09/10), 645-652, 2018 | 27 | 2018 |
| Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts LA Kotzé, C Young, VN Leukes, V John, Z Fang, G Walzl, MB Lutz, ... EBioMedicine 53, 2020 | 26 | 2020 |
| Performance and immune characteristics of bronchoalveolar lavage by research bronchoscopy in pulmonary tuberculosis and other lung diseases in the Western Cape, South Africa C Young, P Ahlers, AM Hiemstra, AG Loxton, A Gutschmidt, ST Malherbe, ... Translational Medicine Communications 4, 1-12, 2019 | 15 | 2019 |
| Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunol. 2020; 13 (2): 190-204 C Young, G Walzl, N Du Plessis | 5 | |
| Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunol [Internet]. 2020; 13 (2): 190–204 C Young, G Walzl, ND Plessis | 4 | |
| Recognition and control of Mycobacterium tuberculosis-infected cells: from basics to the clinic: a NIAID/WGNV workshop report 2023 C Young, MN Mkhonza, P Ogongo Frontiers in Tuberculosis 1, 1303505, 2023 | 2 | 2023 |
| Immunopathology in human tuberculosis TJ Scriba, M Maseeme, C Young, L Taylor, AJ Leslie Science Immunology 9 (102), eado5951, 2024 | 1 | 2024 |
| Meeting report: 6th global forum on tuberculosis vaccines, 22–25 February 2022, Toulouse, France C Young, S Suliman, V Rozot, SC Mendelsohn Vaccine: X 13, 100267, 2023 | 1 | 2023 |
| Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report RA Clark, C Young, S Palmer, E Auma, S Malhotra, R Limaye, B Giersing, ... Frontiers in Tuberculosis 2, 1384036, 2024 | | 2024 |
| PA-709 NK cell determinants of immunity to mycobacterium tuberculosis in humans C Young, G Ahimbisibwe, M Nakibuule, A Leslie, M Rodo, M de Kock, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| " Deep phenotyping" of human myeloid derived suppressor cells from the lungs and blood of patients with tuberculosis and other lung diseases C Young Stellenbosch: Stellenbosch University, 2019 | | 2019 |
| Safety, Reactogenicity, and Immunogenicity of Mtbvac in Infants: A Phase 2a Randomized, Double-Blind, Dose-Defining Trial in a Tb Endemic Setting M Tameris, V Rozot, C Imbratta, H Geldenhuys, SC Mendelsohn, ... | | |
